Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationConstanze Schmidt, Dierk Thomas, Felix Wiedmann et al.|Circulation|2015Cited by 195
Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine modelOlympia Bikou, Dierk Thomas, Kerstin Trappe et al.|Cardiovascular Research|2011Cited by 159
Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion BeamsH. Immo Lehmann, Douglas L. Packer, Dierk Thomas et al.|Scientific Reports|2016Cited by 121
Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot studyKerstin Trappe, Alexander Bauer, Dierk Thomas et al.|European Heart Journal|2011Cited by 103
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus ConferenceLarissa Fabritz, Burcu Vardar, Harry J.G.M. Crijns et al.|EP Europace|2020Cited by 69